Cargando…

A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome

OBJECTIVE: To explore the efficacy and safety of rituximab (RTX) in the treatment of autoimmune nephropathy manifested as refractory nephrotic syndrome (RNS). METHODS: A single-center prospective cohort study was conducted on RNS patients treated with RTX between March 2017 and December 2019. The su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Jing, Ding, Ying, Wan, Li, Yang, Qinghua, Qu, Zhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2021
Materias:	Nephrology - Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732927/ https://www.ncbi.nlm.nih.gov/pubmed/33905043 http://dx.doi.org/10.1007/s11255-021-02860-4

Ejemplares similares

Clinical Profile and Outcomes of Nephrotic Syndrome With Acute Kidney Injury in Adults: A Prospective Cohort Study
por: Yadav, Rajaram, et al.
Publicado: (2023)

Causes of nephrotic syndrome in Sweden: The relevance of clinical presentation and demographics
por: Jönsson, Anneli, et al.
Publicado: (2023)

Use of Bortezomib in the Treatment of C3 Glomerulonephritis Refractory to Eculizumab and Rituximab
por: Hui, Jessica W., et al.
Publicado: (2020)

A Case Report of Fructosamine’s Unreliability as a Glycemic Control Assessment Tool in Nephrotic Syndrome
por: Senapathi, Sri HarshaVardhan, et al.
Publicado: (2017)

Retinal detachments in a patient with minimal change nephrotic syndrome: Case report and review of the literature
por: Ye, Chunjian, et al.
Publicado: (2023)

Bilateral Perinephric Collections in Nephrotic Syndrome
por: Kumar, M. Naveen, et al.
Publicado: (2020)

Nomogram to predict the progression of patients with primary membranous nephropathy and nephrotic syndrome
por: Liu, Lili, et al.
Publicado: (2021)

Case Report: Roxadustat in Combination With Rituximab Was Used to Treat EPO-Induced Pure Red Cell Aplasia
por: You, Xiaoe, et al.
Publicado: (2022)

Pierson Syndrome in an Infant With Congenital Nephrotic Syndrome and Unique Brain Pathology
por: Hiser, Wesley, et al.
Publicado: (2020)

Primary Refractory Catastrophic Antiphospholipid Syndrome Masquerading as Buerger’s Disease
por: Tannous, Toufic, et al.
Publicado: (2021)

Pulmonary Thromboembolism: A Rare but Serious Complication of Nephrotic Syndrome
por: Sandal, S., et al.
Publicado: (2018)

Ischemic Stroke of Possible Embolic Etiology Associated With Nephrotic Syndrome
por: Roy, Claudie, et al.
Publicado: (2017)

Rituximab treatment for refractory nephrotic syndrome in adults: a multicenter retrospective study
por: Ma, Xiaoyan, et al.
Publicado: (2023)

Case Report: Immune checkpoint inhibitor–induced multiorgan vasculitis successfully treated with rituximab
por: Qureshi, Sehrish, et al.
Publicado: (2023)

Acute kidney injury in children with nephrotic syndrome: a single-center study
por: Sharma, Manjuri, et al.
Publicado: (2018)

Rituximab Treatment for Nephrotic Syndrome in Children
por: Iijima, Kazumoto, et al.
Publicado: (2014)

Effectiveness of rituximab in nephrotic syndrome treatment
por: Popko, Katarzyna, et al.
Publicado: (2017)

Cure of Refractory Hypotension in a Hemodialysis Patient
por: Bhatta, Prajjwol D, et al.
Publicado: (2023)

Rituximab for the Treatment of Pediatric Double-Positive Small-Vessel Vasculitis
por: Timmermans, Sjoerd A.M.E.G., et al.
Publicado: (2019)

Disarranged Sphingolipid Metabolism From Sphingosine-1-Phosphate Lyase Deficiency Leads to Congenital Nephrotic Syndrome
por: Taylor, Veronica A., et al.
Publicado: (2019)

Microfilaria associated macroscopic hematuria and nephrotic range proteinuria
por: Prakash, G. K., et al.
Publicado: (2016)

Rituximab for nephrotic syndrome in children
por: Iijima, Kazumoto, et al.
Publicado: (2016)

A randomized controlled trial of preemptive rituximab to prevent recurrent focal segmental glomerulosclerosis post-kidney transplant (PRI-VENT FSGS): protocol and study design
por: Rheault, Michelle N., et al.
Publicado: (2023)

Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis
por: Ameye, Heleen, et al.
Publicado: (2016)

Early Use of Rituximab in Calcineurin Inhibitor–Refractory and Steroid-Resistant Nephrotic Syndrome
por: Sinha, Rajiv, et al.
Publicado: (2020)

Rituximab for Anti–Glomerular Basement Membrane Disease
por: Jain, Rashmi, et al.
Publicado: (2018)

SGLT2 inhibitors in the treatment of type 2 cardiorenal syndrome: Focus on renal tubules
por: Wang, Yajiao, et al.
Publicado: (2023)

The efficacy and safety of rituximab in treating childhood refractory nephrotic syndrome: A meta-analysis
por: Zhao, Zhihong, et al.
Publicado: (2015)

Rituximab-Induced Remission in Epstein−Barr Virus−Associated Glomerulonephritis
por: Alabdaljabar, Mohamad S., et al.
Publicado: (2020)

Rash and Nephrotic Syndrome in a Patient with Rheumatoid Arthritis
por: Hannouneh, Zein Alabdin, et al.
Publicado: (2023)

Mechanism of Abelmoschus manihot L. in the Treatment of Contrast-Induced Nephropathy on the Basis of Network Pharmacology Analysis
por: Xu, Zhongchi, et al.
Publicado: (2022)

An Unusual Kidney Biopsy Finding in a Patient with Nephrotic Syndrome
por: Kawam, Lamees, et al.
Publicado: (2023)

Low-dose Rituximab therapy in resistant idiopathic membranous nephropathy: single-center experience
por: Bagchi, Soumita, et al.
Publicado: (2018)

Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

Rituximab Use in the Management of Childhood Nephrotic Syndrome
por: Kallash, Mahmoud, et al.
Publicado: (2019)

Tumor Lysis Syndrome Caused by Unrecognized Richter’s Transformation of Chronic Lymphocytic Leukemia: Treatment With Venetoclax for Suspected Disease Progression
por: Chango Azanza, Juan Jose, et al.
Publicado: (2020)

Treatment of Concurrent Minimal Change Disease and Epstein Barr Virus–Driven Post-transplant Lymphoproliferative Disorder With Rituximab Following Hematopoietic Stem Cell Transplantation
por: Ainley, Louise, et al.
Publicado: (2020)

Risk factors for imaging abnormalities after the first febrile urinary tract infection in infants ≤3 months old: a retrospective cohort study
por: Chong, Siew Le, et al.
Publicado: (2023)

Hypokalemia after rituximab administration in nephrotic syndrome: two case reports
por: Song, Yiyun, et al.
Publicado: (2023)

Reversal of Dialysis-Dependent Anti–Glomerular Basement Membrane Disease Using Plasma Exchange, Glucocorticosteroids, and Rituximab
por: Lemahieu, Wim, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_j2vro4ngmp6k37853tmt8aa3u4